At a recent panel discussion, healthcare executives agreed that telehealth will remain an important part of care delivery post-pandemic, so now is the time for providers to figure out how best to incorporate these services alongside in-person care. Actionable data will prove to be a key resource for providers as they tweak their strategies.
In a remote work environment, cybersecurity teams learned that they needed to support their organizations by providing workers with the information they needed to secure their data, while also remaining flexible to changing needs, panelists said at a HIMSS Digital session.
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
The company has a 10,000-patient prospective trial with Geisinger fully enrolled to test CancerSEEK, a test developed at Johns Hopkins University.
“Geisinger is prescribing DNA sequencing to patients and putting DNA results in electronic health records and actually creating an action plan to prevent that predisposition from occurring. We are preventing disease from happening,” said Wendy Wilson, a Geisinger spokeswoman.
Members of the Partners in Innovation, Education, and Research consortium include Atlantic Health System, Drexel University, Einstein Healthcare Network, Geisinger including AtlantiCare, Main Line Health, and Thomas Jefferson University.
Are portals delivering on their promise to engage patients? Or are these results too often a source of confusion and alarm for patients and the cause of more work for doctors because information is provided with little to no guidance?
At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.
The Danville, Pennsylvania-based system plans to work with rabbittransit to help patients get to their appointments on time. Additionally, researchers from Geisinger and Regeneron Genetics Center recently found a gene variant that's associated with a reduction in the risk for chronic liver disease.
In a recent phone interview, Geisinger's new chief innovation officer, Karen Murphy, discussed her new role and the future of healthcare transformation.
One element of the program involves a fresh food pharmacy — an initiative that "prescribes" a food program for diabetic, food-insecure patients.
One of the most drastic changes resulting from the survey was the implementation of a formal dress code for RNs. In January, RNs began wearing pewter gray and white scrub uniforms embroidered with the Geisinger logo and the designation “Registered Nurse.”
We will highlight Build My Health's revenue practice management tools, which could help physician practices add up to $250,000 to their practices.
Ryu wasn’t familiar with the recent inflammatory comments by American Medical Association CEO Dr. James Madara, who compared digital health to "snake oil," but Ryu said he was a fan of a lot of technologies in healthcare.
The Geisinger Health System empire is bringing its model of value-based care to the Atlantic City area.
This week, Geisinger Health System in Pennsylvania opened the doors of its Geisinger Precision Health Center, including a telemedicine genomics program, while Swedish Cancer Institute, part of Seattle's Swedish Medical Center, announced that it would install software to mine EHR and genomic records to match patients' genetic mutations to treatments most appropriate to their tumors.
There’s been a flurry of news related to telemedicine this week, with several notable developments in Mississippi and Silicon Valley. One of the more interesting aspects of telemedicine is that much of the innovation and focus of late has come from startups and vendors, while health systems have shown a bit of reluctance to deploy […]
The Morning Read provides a 24-hour wrap up of everything else healthcare’s innovators need to know about the business of medicine (and beyond). The author of The Read published it but all full-time MedCity News journalists contribute to its content. TOP STORIES The FDA has taken a big next step in establishing a medical device […]